Found 41 matching trials
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction PHASE1 This phase II trial studies the side effects and how well Vyxeos works in t...
Show More Location
UC Davis Comprehensive Cancer Center
Learn More & Join Trial
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML PHASE2 The goal of this clinical trial is to estimate the rate (probability) of co...
Show More Location
First Affiliated Hospital Of University of Science and Technology of China
Learn More & Join Trial
Vyxeos® With Clofarabine for Pediatric AML PHASE1 Treatment with intensive chemotherapy in AML results in approximately 70% s...
Show More Location
St. Anna Kinderspital
Learn More & Join Trial
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease PHASE2 This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes PHASE2 This phase II trial studies the effect of adding pomalidomide to usual chem...
Show More Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Learn More & Join Trial
Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia PHASE1 This phase I trial studies the best dose and side effects of liposomal cyta...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) PHASE2 This study examines the use of denileukin diftitox (Ontak) for patients wit...
Show More Location
Washington University
Learn More & Join Trial
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia PHASE2 Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old PHASE2 This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Show More Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Learn More & Join Trial
EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML N/A This study is a Phase IV Expanded Access Protocol (EAP) of CPX-351 in patie...
Show More Status
Approved For Marketing
Location
UCLA Ronald Reagan Medical Center
Learn More & Join Trial